Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Prevent Unnecessary Use of Psychotropic Medication

Albuquerque, New Mexico Survey Completed on 11-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Staff administered Haldol, an antipsychotic medication, to a resident with severe dementia and agitation on multiple occasions without a qualifying diagnosis and without first attempting other interventions. The resident's care plan indicated behavioral issues such as anger, resistance to care, wandering, and exit-seeking, with interventions including medication administration, monitoring for side effects, and psychiatric referral. Despite these interventions, the resident received Haldol injections repeatedly, as documented in the Medication Administration Record and nursing progress notes, often in response to agitation, verbal threats, or physical aggression. The documentation revealed that staff did not consistently record the reasons for administering Haldol, and in at least one instance, there was no nursing progress note to justify the use of the medication. Interviews with facility staff, including the Social Services Assistant and Unit Manager, indicated that the resident's behaviors were attributed to his dissatisfaction with being at the facility, and that medication should not have been the first intervention. The Unit Manager specifically stated that staff were expected to try other interventions before resorting to Haldol, and that medication should not be the initial response to behavioral issues. The Physician Assistant who ordered the Haldol stated it was intended for severe agitation and that suicidal threats alone did not warrant its use. The PA also acknowledged that staff could interpret 'extreme agitation' subjectively, potentially leading to inconsistent administration of the medication. The repeated use of Haldol without documented attempts at alternative interventions and without a clear qualifying diagnosis constituted the deficiency identified by surveyors.

An unhandled error has occurred. Reload 🗙